Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m.
Pharmaceuticals
2019,
12
, 13
Pharmaceuticals (Basel)
.
2019 Jun 13;12(2):88.
doi: 10.3390/ph12020088.
Authors
Maximilian Klingler
1
,
Christine Rangger
2
,
Dominik Summer
3
,
Piriya Kaeopookum
4
,
Clemens Decristoforo
5
,
Elisabeth von Guggenberg
6
Affiliations
1
Department of Nuclear Medicine, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria. maximilian.klingler@i-med.ac.at.
2
Department of Nuclear Medicine, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria. christine.rangger@i-med.ac.at.
3
Department of Nuclear Medicine, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria. summer.dominik@gmail.com.
4
Department of Nuclear Medicine, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria. piriya.kaeopookum@student.i-med.ac.at.
5
Department of Nuclear Medicine, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria. clemens.decristoforo@i-med.ac.at.
6
Department of Nuclear Medicine, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria. elisabeth.von-guggenberg@i-med.ac.at.
PMID:
31200592
PMCID:
PMC6631989
DOI:
10.3390/ph12020088
Abstract
In our paper [...].
Publication types
Published Erratum
Grants and funding
P 27844/FWF_/Austrian Science Fund FWF/Austria